A 0 1 0 1 O
female 2 8 2 8 B-gender
of 9 11 9 11 O
child 12 17 12 17 O
- 17 18 17 18 O
bearing 18 25 18 25 O
potential 26 35 26 35 O
is 36 38 36 38 O
any 39 42 39 42 O
woman 43 48 43 48 B-gender
( 49 50 49 50 O
regardless 50 60 50 60 O
of 61 63 61 63 O
sexual 64 70 64 70 O
orientation 71 82 71 82 O
, 82 83 82 83 O
having 84 90 84 90 O
undergone 91 100 91 100 O
a 101 102 101 102 O
tubal 103 108 103 108 O
ligation 109 117 109 117 O
, 117 118 117 118 O
or 119 121 119 121 O
remaining 122 131 122 131 O
celibate 132 140 132 140 O
by 141 143 141 143 O
choice 144 150 144 150 O
) 150 151 150 151 O

ANC 0 3 152 155 B-clinical_variable
< 4 5 156 157 O
500 6 9 158 161 B-upper_bound
/ 9 10 161 162 I-upper_bound
ml 10 12 162 164 I-upper_bound

Adjuvant 0 8 165 173 B-treatment
systemic 9 17 174 182 I-treatment
therapy 18 25 183 190 I-treatment
before 26 32 191 197 O
and 33 36 198 201 O
after 37 42 202 207 O
the 43 46 208 211 O
protocol 47 55 212 220 O
therapy 56 63 221 228 O
per 64 67 229 232 O
section 68 75 233 240 O
4.4.1 76 81 241 246 O

Age 0 3 247 250 B-age
≥ 4 5 251 252 O
18 6 8 253 255 B-lower_bound
years 9 14 256 261 I-lower_bound
old 15 18 262 265 O

Albumin 0 7 266 273 B-clinical_variable
< 8 9 274 275 O
2.5 10 13 276 279 B-upper_bound

At 0 2 280 282 O
least 3 8 283 288 O
4 9 10 289 290 B-lower_bound
weeks 11 16 291 296 I-lower_bound
must 17 21 297 301 O
have 22 26 302 306 O
passed 27 33 307 313 O
since 34 39 314 319 O
the 40 43 320 323 O
last 44 48 324 328 O
directed 49 57 329 337 O
intervention 58 70 338 350 O
to 71 73 351 353 O
the 74 77 354 357 O
protocol 78 86 358 366 O
- 86 87 366 367 O
treated 87 94 367 374 O
lesion 95 101 375 381 O

Contraindications 0 17 382 399 O
to 18 20 400 402 O
general 21 28 403 410 B-allergy_name
anesthesia 29 39 411 421 I-allergy_name

Has 0 3 422 425 O
not 4 7 426 429 O
been 8 12 430 434 O
naturally 13 22 435 444 O
postmenopausal 23 37 445 459 O
for 38 41 460 463 O
at 42 44 464 466 O
least 45 50 467 472 O
12 51 53 473 475 B-lower_bound
consecutive 54 65 476 487 I-lower_bound
months 66 72 488 494 I-lower_bound
( 73 74 495 496 O
i.e. 74 78 496 500 O
, 78 79 500 501 O
has 80 83 502 505 O
had 84 87 506 509 O
menses 88 94 510 516 O
at 95 97 517 519 O
any 98 101 520 523 O
time 102 106 524 528 O
in 107 109 529 531 O
the 110 113 532 535 O
preceding 114 123 536 545 B-upper_bound
12 124 126 546 548 I-upper_bound
consecutive 127 138 549 560 I-upper_bound
months 139 145 561 567 I-upper_bound
) 145 146 567 568 O

Hb 0 2 569 571 B-clinical_variable
level 3 8 572 577 I-clinical_variable
< 9 10 578 579 O
8 11 12 580 581 B-upper_bound
gm 13 15 582 584 I-upper_bound
/ 15 16 584 585 I-upper_bound
dl 16 18 585 587 I-upper_bound

History 0 7 588 595 O
of 8 10 596 598 O
Crohn 11 16 599 604 B-chronic_disease
's 16 18 604 606 I-chronic_disease
Disease 19 26 607 614 I-chronic_disease
or 27 29 615 617 O
Ulcerative 30 40 618 628 B-chronic_disease
Colitis 41 48 629 636 I-chronic_disease

KPS 0 3 637 640 B-clinical_variable
≥ 4 5 641 642 O
60 6 8 643 645 B-lower_bound
( 9 10 646 647 O
See 10 13 647 650 O
Appendix 14 22 651 659 O
B 23 24 660 661 O
) 24 25 661 662 O

LT 0 2 663 665 B-clinical_variable
/ 2 3 665 666 O
AST 3 6 666 669 B-clinical_variable
> 7 8 670 671 O
5 9 10 672 673 B-lower_bound
X 11 12 674 675 I-lower_bound
ULN 13 16 676 679 I-lower_bound

Lesion 0 6 680 686 B-clinical_variable
size 7 11 687 691 I-clinical_variable
≥ 12 13 692 693 O
3 14 15 694 695 B-lower_bound
cm 15 17 695 697 I-lower_bound
in 18 20 698 700 O
maximum 21 28 701 708 O
dimension 29 38 709 718 O

Men 0 3 719 722 B-gender
and 4 7 723 726 O
women 8 13 727 732 B-gender
of 14 16 733 735 O
reproductive 17 29 736 748 O
potential 30 39 749 758 O
may 40 43 759 762 O
not 44 47 763 766 O
participate 48 59 767 778 O
unless 60 66 779 785 O
they 67 71 786 790 O
agree 72 77 791 796 B-contraception_consent
to 78 80 797 799 I-contraception_consent
use 81 84 800 803 I-contraception_consent
an 85 87 804 806 I-contraception_consent
effective 88 97 807 816 I-contraception_consent
contraceptive 98 111 817 830 I-contraception_consent
method 112 118 831 837 I-contraception_consent

Patients 0 8 838 846 O
must 9 13 847 851 O
have 14 18 852 856 O
histologic 19 29 857 867 O
or 30 32 868 870 O
radiographic 33 45 871 883 O
proof 46 51 884 889 O
of 52 54 890 892 O
a 55 56 893 894 O
primary 57 64 895 902 B-cancer
liver 65 70 903 908 I-cancer
malignancy 71 81 909 919 I-cancer
suitable 82 90 920 928 O
for 91 94 929 932 O
radiation 95 104 933 942 B-treatment
therapy 105 112 943 950 I-treatment

Patients 0 8 951 959 O
who 9 12 960 963 O
are 13 16 964 967 O
on 17 19 968 970 O
anticoagulation 20 35 971 986 B-treatment
medication 36 46 987 997 I-treatment
that 47 51 998 1002 O
may 52 55 1003 1006 O
not 56 59 1007 1010 O
be 60 62 1011 1013 O
safely 63 69 1014 1020 O
held 70 74 1021 1025 O
for 75 78 1026 1029 O
the 79 82 1030 1033 O
procedure 83 92 1034 1043 O
( 93 94 1044 1045 O
≥ 94 95 1045 1046 O
5 96 97 1047 1048 B-lower_bound
days 98 102 1049 1053 I-lower_bound
for 103 106 1054 1057 O
antiplatelet 107 119 1058 1070 B-treatment
agents 120 126 1071 1077 I-treatment
and 127 130 1078 1081 O
warfarin 131 139 1082 1090 B-treatment
; 139 140 1090 1091 O
≥ 141 142 1092 1093 O
24 143 145 1094 1096 B-lower_bound
hours 146 151 1097 1102 I-lower_bound
for 152 155 1103 1106 O
low 156 159 1107 1110 B-clinical_variable
- 159 160 1110 1111 I-clinical_variable
molecular 160 169 1111 1120 I-clinical_variable
weight 170 176 1121 1127 I-clinical_variable
heparin 177 184 1128 1135 I-clinical_variable
formulations 185 197 1136 1148 I-clinical_variable
) 197 198 1148 1149 O
will 199 203 1150 1154 O
be 204 206 1155 1157 O
excluded 207 215 1158 1166 O

Pregnant 0 8 1167 1175 B-pregnancy
or 9 11 1176 1178 O
lactating 12 21 1179 1188 O
women 22 27 1189 1194 B-gender

Should 0 6 1195 1201 O
a 7 8 1202 1203 O
woman 9 14 1204 1209 B-gender
become 15 21 1210 1216 B-pregnancy
pregnant 22 30 1217 1225 I-pregnancy
or 31 33 1226 1228 O
suspect 34 41 1229 1236 O
she 42 45 1237 1240 O
is 46 48 1241 1243 O
pregnant 49 57 1244 1252 O
while 58 63 1253 1258 O
participating 64 77 1259 1272 O
in 78 80 1273 1275 O
this 81 85 1276 1280 O
study 86 91 1281 1286 O
, 91 92 1286 1287 O
she 93 96 1288 1291 O
should 97 103 1292 1298 O
inform 104 110 1299 1305 O
her 111 114 1306 1309 O
treating 115 123 1310 1318 O
physician 124 133 1319 1328 O
immediately 134 145 1329 1340 O

Women 0 5 1341 1346 B-gender
of 6 8 1347 1349 O
child 9 14 1350 1355 O
- 14 15 1355 1356 O
bearing 15 22 1356 1363 O
potential 23 32 1364 1373 O
and 33 36 1374 1377 O
men 37 40 1378 1381 O
must 41 45 1382 1386 O
agree 46 51 1387 1392 B-contraception_consent
to 52 54 1393 1395 I-contraception_consent
use 55 58 1396 1399 I-contraception_consent
adequate 59 67 1400 1408 I-contraception_consent
contraception 68 81 1409 1422 I-contraception_consent
( 82 83 1423 1424 O
hormonal 83 91 1424 1432 B-contraception_consent
or 92 94 1433 1435 I-contraception_consent
barrier 95 102 1436 1443 I-contraception_consent
method 103 109 1444 1450 I-contraception_consent
of 110 112 1451 1453 I-contraception_consent
birth 113 118 1454 1459 I-contraception_consent
control 119 126 1460 1467 I-contraception_consent
; 126 127 1467 1468 O
abstinence 128 138 1469 1479 B-contraception_consent
) 138 139 1479 1480 O
prior 140 145 1481 1486 O
to 146 148 1487 1489 O
study 149 154 1490 1495 O
entry 155 160 1496 1501 O
, 160 161 1501 1502 O
for 162 165 1503 1506 O
the 166 169 1507 1510 O
duration 170 178 1511 1519 O
of 179 181 1520 1522 O
study 182 187 1523 1528 O
participation 188 201 1529 1542 O
, 201 202 1542 1543 O
and 203 206 1544 1547 O
for 207 210 1548 1551 O
90 211 213 1552 1554 B-upper_bound
days 214 218 1555 1559 I-upper_bound
following 219 228 1560 1569 O
completion 229 239 1570 1580 O
of 240 242 1581 1583 O
therapy 243 250 1584 1591 B-treatment

all 0 3 1592 1595 O
patients 4 12 1596 1604 O
must 13 17 1605 1609 O
be 18 20 1610 1612 O
evaluated 21 30 1613 1622 O
by 31 33 1623 1625 O
the 34 37 1626 1629 O
Liver 38 43 1630 1635 B-treatment
Tumor 44 49 1636 1641 I-treatment
Program 50 57 1642 1649 I-treatment
at 58 60 1650 1652 O
conference 61 71 1653 1663 O
before 72 78 1664 1670 O
brachytherapy 79 92 1671 1684 B-treatment
treatment 93 102 1685 1694 I-treatment
for 103 106 1695 1698 O
discussion 107 117 1699 1709 O
and 118 121 1710 1713 O
consideration 122 135 1714 1727 O
of 136 138 1728 1730 O
other 139 144 1731 1736 O
options 145 152 1737 1744 O
for 153 156 1745 1748 O
treatment 157 166 1749 1758 O
of 167 169 1759 1761 O
liver 170 175 1762 1767 B-cancer
cancer 176 182 1768 1774 I-cancer
including 183 192 1775 1784 O
surgical 193 201 1785 1793 B-treatment
resection 202 211 1794 1803 I-treatment

surgery 0 7 1804 1811 B-treatment
or 8 10 1812 1814 O
other 11 16 1815 1820 O
ablative 17 25 1821 1829 B-treatment
therapy 26 33 1830 1837 I-treatment
is 34 36 1838 1840 O
allowed 37 44 1841 1848 O
for 45 48 1849 1852 O
lesions 49 56 1853 1860 O
appearing 57 66 1861 1870 O
after 67 72 1871 1876 O
enrollment 73 83 1877 1887 O
to 84 86 1888 1890 O
this 87 91 1891 1895 O
protocol 92 100 1896 1904 O
as 101 103 1905 1907 O
per 104 107 1908 1911 O
section 108 115 1912 1919 O
4.4.2 116 121 1920 1925 O
and 122 125 1926 1929 O
4.4.3 126 131 1930 1935 O
is 132 134 1936 1938 O
allowed 135 142 1939 1946 O

